SecBot SecBot
SECBOTREPLAY Home › Report › CGON

CGON · CG Oncology director Leonard Post filed a Form 144 indicating intent to…

CG Oncology, Inc. · 144 filed Jun 22, 2026 at 16:49 ET

At the news

NEUTRALIMPACT 3/10

144 filed Jun 22, 2026 at 16:49 ET

CG Oncology director Leonard Post filed a Form 144 indicating intent to sell 6,000 shares (~$366K) under a 10b5-1 plan, likely to exercise stock options. The sale is small relative to market cap ($5.4B) and pre-planned, carrying minimal signal.

  • Insider: Leonard E. Post, Director
  • Shares to sell: 6,000 common shares
  • Estimated value: $366,480 (based on $61.08/share)
  • Sale method: Morgan Stanley Smith Barney, pre-arranged 10b5-1 plan

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access